Unlocking the Power of Molecular Testing in Chronic Myeloid Leukemia: from Diagnosis to Deep ResponseMonitoring
Speaker Dr. Cristiana Tresoldi In this session, Dr. Tresoldi delves into the crucial role of molecular biomarkers in the diagnosis and management of Chronic Myeloid Leukemia (CML), showcasing how optimized molecular testing strategies can enhance diagnostic accuracy, enable deep response monitoring, and improve overall disease management. Join Webinar
Maximizing Oncology Molecular Testing: The Power of Integrated RT-PCR and NGS Systems
Speaker Dr. Rossella Bruno Molecular Biologist, Lab of Molecular Pathology, University Hospital of Pisa (Italy) In this session, Dr. Bruno will explore how the integration of RT-PCR and Next Generation Sequencing (NGS) enhances the efficiency and accuracy of molecular testing in oncology. Join Webinar
Unlocking precision medicine: The Clinical Role of BRCA 1/2 Molecular Testing
Speaker Dr. Maria Scatolini,PhD – Head, Molecular Oncology Laboratory Edo ed Elvo Tempia Foundation, Biella (Italy) Join this webinar to explore how NGS-based BRCA1/2 testing—covering workflow, pre-analytics, and bioinformatics—drives meaningful impact in oncology, featuring real-life laboratory experience and data across blood, FFPE, and liquid biopsy samples. Join Webinar
Precision Oncology: DPYD and UGT1A1 Testing for Safer Chemotherapy in Real-World Practice
Speakers Dr. Erika Cecchin, PharmD, PhD Clinical Pharmacologist –Experimental and Clinical Pharmacology (ECP) Aviano National Cancer Institute (CRO), IRCCS (italy) “Personalizing Cancer Therapy Through Pharmacogenetics: DPYD, UGT1A1 and beyond” Dr. Stefania Tommasi Head – Unit of Molecular Diagnostics and Pharmacogenetics Giovanni Paolo II Cancer Institute, Bari (Italy) “Implementing DPYD and UGT1A1 Testing in Clinical Practice” […]